Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS), 35389-35390 [2019-15588]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices
Telephone (770) 488–4518, Fax (770)
488–4760. Email: acbcyw@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly
among those at heightened risk) and
promote the early detection and support
of young women who develop the
disease. The advice provided by the
Committee will assist in ensuring
scientific quality, timeliness, utility, and
dissemination of credible appropriate
messages and resource materials.
Matters To Be Considered: The agenda
will include discussions on current and
emerging topics related to breast cancer
in young women. These will include
public health communication, breast
cancer in young women digital and
social media campaign, CDC updates,
and updates from the field. Agenda
items are subject to change as priorities
dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
RFA–IP20–001, Epidemiology,
Prevention, and Treatment of Influenza
and Other Respiratory Infections in
Panama and Other Countries in the
Americas.
Date: August 13, 2019.
Time: 10:00 a.m.–11:30 a.m., (EDT).
Place: Teleconference, Centers for
Disease Control and Prevention, Room
1080, 8 Corporate Square Blvd., Atlanta,
GA 30329.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE, Mailstop US8–1,
Atlanta, Georgia 30329, (404) 718–8833,
gca5@cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–15587 Filed 7–22–19; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2019–15593 Filed 7–22–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Statistics
(BSC, NCHS)
jspears on DSK30JT082PROD with NOTICES
Notice of Closed Meeting
VerDate Sep<11>2014
16:43 Jul 22, 2019
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
Jkt 247001
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Health Statistics
(BSC, NCHS). This meeting is open to
the public; limited only by available
seating. The meeting room
accommodates approximately 78
people. Requests to make oral
presentations should be submitted in
writing to Gwen Mustaf, 301–458–4500,
SUMMARY:
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
35389
glm4@cdc.gov, or Sayeedha Uddin,
isx9@cdc.gov. All requests must contain
the name, address, telephone number,
and organizational affiliation of the
presenter. Written comments should not
exceed five single-spaced typed pages in
length and must be received by August
14, 2019.
DATES: The meeting will be held on
September 5, 2019, 11:00 a.m.–5:30
p.m., EDT, and September 6, 2019, 8:30
a.m.–1:00 p.m., EDT.
ADDRESSES: NCHS Headquarters, 3311
Toledo Road, Hyattsville, Maryland
20782.
FOR FURTHER INFORMATION CONTACT:
Sayeedha Uddin, M.D., M.P.H.,
Executive Secretary, NCHS/CDC, Board
of Scientific Counselors, 3311 Toledo
Road, Room 2627, Hyattsville, Maryland
20782, telephone (301) 458–4303, email
isx9@cdc.gov.
SUPPLEMENTARY INFORMATION: All
visitors must be processed in
accordance with established federal
policies and procedures. For foreign
nationals or non-U.S. citizens, preapproval is required (please contact
Gwen Mustaf, 301–458–4500, glm4@
cdc.gov or Sayeedha Uddin, isx9@
cdc.gov at least 10 days in advance for
requirements). All visitors are required
to present a valid form of picture
identification issued by a state, federal
in international government. As
required by the Federal Property
Management Regulations, Title 41, Code
of Federal Regulations, Subpart 101–
20.301, all persons entering in or on
Federal controlled property and their
packages, briefcases, and other
containers in their immediate
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession of the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances.
Purpose: This committee is charged
with providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NCHS, regarding the scientific
and technical program goals and
objectives, strategies, and priorities of
NCHS.
Matters To Be Considered: Day 1
meeting agenda includes welcome
remarks and a Center update by NCHS
leadership; update on Patient Centered
Outcomes Research Trust Fund Drug
Workgroup Report; update on Patient
Centered Outcomes Research Trust
Fund Projects; update on Evidence
Based Policy Making; update on
National Health Interview Survey
Redesign. Day 2 meeting agenda
E:\FR\FM\23JYN1.SGM
23JYN1
35390
Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices
includes update on Maternal Mortality
Data; report on NCHS Outreach
Planning.
Chief Operating Officer, Centers for
Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–15588 Filed 7–22–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–15591 Filed 7–22–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), Subcommittee on
Dose Reconstruction Review (SDRR),
National Institute for Occupational
Safety and Health (NIOSH)
Notice of Closed Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
PAR 18–812, NIOSH Member Conflict.
Date: October 29, 2019.
Time: 1:00 p.m.–4:00 p.m. EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Nina
Turner, Ph.D., Scientific Reviewer
Officer, Office of Extramural Programs,
1095 Willowdale Road, Morgantown,
West Virginia 26506, (304) 285–5976,
nxt2@cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Subcommittee for Dose
Reconstruction Reviews (SDRR) of the
Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, but without a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
audio conference (information below).
The audio conference line has 150 ports
for callers.
DATES: The meeting will be held on
September 12, 2019, 10:30 a.m. to 4:00
p.m. EDT.
ADDRESSES: Audio Conference Call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537; the
passcode is 9933701.
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road NE, Mailstop E–20,
Atlanta, Georgia 30329, Telephone (513)
533–6800, Toll Free 1 (800)CDC–INFO,
Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
AGENCY:
Centers for Disease Control and
Prevention
jspears on DSK30JT082PROD with NOTICES
Prevention and the Agency for Toxic
Substances and Disease Registry.
VerDate Sep<11>2014
16:43 Jul 22, 2019
Jkt 247001
SUMMARY:
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
rechartered on February 12, 2018,
pursuant to Executive Order 13708, and
will terminate on September 30, 2019.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
SDRR was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Considered: The agenda
will include discussions on the
following dose reconstruction program
quality management and assurance
activities: A draft report on the current
progress and findings of dose
reconstruction reviews for the Secretary,
HHS; Dose reconstruction cases under
review from Sets 25 and 26, possibly
including cases involving Albuquerque
Operations Office, Ames Laboratory,
Aliquippa Forge, Battelle Memorial
Institute, General Steel Industries,
Hanford, Hooker Electrochemical, Los
Alamos National Laboratory,
Mallinckrodt Chemical Company,
Nuclear Metals Inc., Pacific Northwest
National Laboratories, Oak Ridge
facilities (Y–12, K–25, X–10), Paducah
Gaseous Diffusion Plant, Pantex Plant,
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 84, Number 141 (Tuesday, July 23, 2019)]
[Notices]
[Pages 35389-35390]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15588]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Health
Statistics (BSC, NCHS)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Health Statistics (BSC, NCHS). This meeting is open
to the public; limited only by available seating. The meeting room
accommodates approximately 78 people. Requests to make oral
presentations should be submitted in writing to Gwen Mustaf, 301-458-
4500, [email protected], or Sayeedha Uddin, [email protected]. All requests must
contain the name, address, telephone number, and organizational
affiliation of the presenter. Written comments should not exceed five
single-spaced typed pages in length and must be received by August 14,
2019.
DATES: The meeting will be held on September 5, 2019, 11:00 a.m.-5:30
p.m., EDT, and September 6, 2019, 8:30 a.m.-1:00 p.m., EDT.
ADDRESSES: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland
20782.
FOR FURTHER INFORMATION CONTACT: Sayeedha Uddin, M.D., M.P.H.,
Executive Secretary, NCHS/CDC, Board of Scientific Counselors, 3311
Toledo Road, Room 2627, Hyattsville, Maryland 20782, telephone (301)
458-4303, email [email protected].
SUPPLEMENTARY INFORMATION: All visitors must be processed in accordance
with established federal policies and procedures. For foreign nationals
or non-U.S. citizens, pre-approval is required (please contact Gwen
Mustaf, 301-458-4500, [email protected] or Sayeedha Uddin, [email protected] at
least 10 days in advance for requirements). All visitors are required
to present a valid form of picture identification issued by a state,
federal in international government. As required by the Federal
Property Management Regulations, Title 41, Code of Federal Regulations,
Subpart 101-20.301, all persons entering in or on Federal controlled
property and their packages, briefcases, and other containers in their
immediate possession are subject to being x-rayed and inspected.
Federal law prohibits the knowing possession of the causing to be
present of firearms, explosives and other dangerous weapons and illegal
substances.
Purpose: This committee is charged with providing advice and making
recommendations to the Secretary, Department of Health and Human
Services; the Director, CDC; and the Director, NCHS, regarding the
scientific and technical program goals and objectives, strategies, and
priorities of NCHS.
Matters To Be Considered: Day 1 meeting agenda includes welcome
remarks and a Center update by NCHS leadership; update on Patient
Centered Outcomes Research Trust Fund Drug Workgroup Report; update on
Patient Centered Outcomes Research Trust Fund Projects; update on
Evidence Based Policy Making; update on National Health Interview
Survey Redesign. Day 2 meeting agenda
[[Page 35390]]
includes update on Maternal Mortality Data; report on NCHS Outreach
Planning.
Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-15588 Filed 7-22-19; 8:45 am]
BILLING CODE 4163-18-P
